Dr Andrew Cameron Wood

Selected publications and creative works (Research Outputs)

As of 29 October 2020 there will be no automatic updating of 'selected publications and creative works' from Research Outputs. Please continue to keep your Research Outputs profile up to date.
  • Wood, A. C., Krytska, K., Ryles, H. T., Infarinato, N. R., Sano, R., Hansel, T. D., ... Ainscow, E. (2017). Dual ALK and CDK4/6 inhibition demonstrates synergy against neuroblastoma. Clinical Cancer Research, 23 (11), 2856-2868. 10.1158/1078-0432.CCR-16-1114
  • Oldridge, D. A., Wood, A. C., Weichert-Leahey, N., Crimmins, I., Sussman, R., Winter, C., ... Zhu, S. (2015). Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Nature, 528 (7582), 418-421. 10.1038/nature15540
  • Wood, A. C., Maris, J. M., Gorlick, R., Kolb, E. A., Keir, S. T., Reynolds, C. P., ... Whiteman, K. (2013). Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program. Pediatric Blood & Cancer, 60 (11), 1860-1867. 10.1002/pbc.24647
  • Bresler, S. C., Wood, A. C., Haglund, E. A., Courtright, J., Belcastro, L. T., Plegaria, J. S., ... Carpenter, E. L. (2011). Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma. Science translational medicine, 3 (108)10.1126/scitranslmed.3002950
  • Balamuth, N. J., Wood, A., Wang, Q., Jagannathan, J., Mayes, P., Zhang, Z., ... Pawel, B. (2010). Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma target. Cancer research, 70 (7), 2749-2758. 10.1158/0008-5472.can-09-3844

Contact details

Primary office location

M&HS BUILDING 504 - Bldg 504
Level 3, Room 338
New Zealand